Order Now, Ships Today
One-time
| Quantity | Discount | Discounted price |
| 3 - 4 | 5% | $123.45 |
| 5 - 6 | 7% | $120.85 |
| 7 - 8 | 9% | $118.25 |
| 9 + | 11% | $115.66 |
These products are for laboratory research only and not intended for medical use. They are not FDA-approved to diagnose, treat, cure, or prevent any disease. By purchasing, you certify they will be used solely for research and not for human or animal consumption.
Cerebrolysin is a research-grade neuropeptide preparation developed for laboratory investigation of neurotrophic signaling and neuroregeneration pathways. This compound consists of a defined mixture of low-molecular-weight peptide fragments and free amino acids that are reported to mimic endogenous neurotrophic factors, making it a valuable tool for studying neuronal survival, plasticity, and repair in experimental models. Current research focuses on understanding how its multimodal composition influences neuroprotective signaling, Trk receptor activation, and downstream cellular pathways under controlled laboratory conditions. Cerebrolysin is classified as a neurotrophic research preparation and is supplied strictly for research use only.
This research preparation is verified for identity and composition consistency by HPLC, amino-acid profiling, and molecular-weight distribution. Certificate: COA: Cerebrolysin (60 mg)
Products from Elite Miami Peptides do not include usage instructions, as they are strictly for in vitro research and prohibited by law for human or animal use. Misuse or unlawful application will result in permanent denial of service.
Each vial contains exactly what’s indicated on the label. For instance, a 10mg vial contains precisely 10mg of lyophilized peptide. Researchers may divide it into smaller research portions—such as four 2.5mg aliquots—but the total content remains the same.
Yes. All peptides are supplied in lyophilized powder form and do not come reconstituted. Any extra materials required for research, such as solvents or diluents, must be obtained separately.
When stored as a dry powder, peptides remain stable for up to 2 years.
Once reconstituted, the solution should be kept refrigerated and is typically stable for up to 2 months under proper storage conditions.
Cerebrolysin is a laboratory research preparation being studied for its interaction with neurotrophic signaling pathways. In controlled research environments, its low-molecular-weight peptide fraction has been reported to interact with Trk receptor signaling and downstream MAPK/ERK and PI3K/Akt cascades, supporting investigations into neuronal survival, neuroprotection, synaptic plasticity, and neuroregeneration. Research involving Cerebrolysin focuses on how its multimodal peptide composition influences complex neurological pathways in experimental models. These studies are limited to laboratory and preclinical settings, and no conclusions regarding safety, efficacy, or application have been established.
Cerebrolysin is a neuropeptide preparation studied in research settings for how its low-molecular-weight peptide fragments interact with neurotrophic signaling pathways. These pathways are associated with neuronal survival, neuroprotection, synaptic plasticity, and neuroregeneration in experimental models. Researchers are interested in this preparation because its multimodal composition provides a broad tool for studying neurotrophic signaling, growth factor mimicry, and neuronal repair mechanisms in controlled laboratory environments. All research involving this compound is limited to experimental models.
⚠️ Disclaimer: this product is not approved for medical use and is not intended to diagnose, treat, or prevent any disease. All information provided is for educational and research purposes only, and this product must never be used in humans or animals.
The development of Cerebrolysin builds upon decades of research into neurotrophic signaling and neuroprotection. Originally developed in the 1980s from purified porcine brain tissue, researchers have investigated its low-molecular-weight peptide fraction for its ability to mimic endogenous growth factors involved in neuronal survival, plasticity, and regeneration. Cerebrolysin expands on this research through its multimodal composition, providing a broad tool for studying neurotrophic and neuroprotective pathways in experimental models. This unique preparation represents an important advancement in neuroscience research and neuroregeneration studies conducted under controlled laboratory conditions.
Classification: Porcine-derived neuropeptide complex Composition: ~25% low-molecular-weight peptides (
Cerebrolysin has been studied in preclinical and neuroscience research models for its multimodal interaction with neurotrophic signaling pathways. Its reported ability to mimic endogenous growth factors has made it a subject of interest in neuroprotection, neuroregeneration, and synaptic plasticity research. Primary Research Observations (Laboratory Context): • Neurotrophic Signaling: Mimicry of BDNF, NGF, GDNF, and CNTF pathways • Neuroprotection Research: Investigation of neuronal survival mechanisms under experimental stress models • Neuroregeneration: Use in studying synaptic plasticity, neurite outgrowth, and Trk-coupled MAPK/ERK and PI3K/Akt signaling pathways Overall, laboratory data suggests that Cerebrolysin may serve as a valuable research preparation for studying neurotrophic signaling, neuroprotection, and complex neuroregenerative mechanisms under controlled research conditions.
In simple terms, Cerebrolysin is being studied for how its low-molecular-weight peptide fragments interact with neurotrophic signaling pathways in laboratory settings. These pathways are associated with how the brain protects, repairs, and regenerates nerve cells through mechanisms similar to the body's own growth factors. Because of its multimodal composition, researchers use this preparation to explore neuronal survival, synaptic plasticity, and neuroregeneration in controlled experimental models. All findings are limited to research environments.
EVER Pharma. Cerebrolysin® Scientific and Technical Documentation. EVER Pharma GmbH. Yang, X. et al. (2023). Characterization of the active peptide constituents of Cerebrolysin using nanoLC-MS analysis.
Our specialists respond within minutes to any order or product inquiry.
These products are for laboratory research only and not intended for medical use. They are not FDA-approved to diagnose, treat, cure, or prevent any disease. By purchasing, you certify they will be used solely for research and not for human or animal consumption.
All compounds from Elite Miami Peptides are intended strictly for laboratory research purposes.
They are not for human use, consumption, or therapeutic applications.
Products are supplied exclusively to qualified professionals working in compliance with all applicable laws and regulations.
